IRIS UniCatt

Armuzzi, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.357
EU - Europa 8.629
AS - Asia 7.258
SA - Sud America 1.407
AF - Africa 191
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 26.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.068
DE - Germania 3.704
SG - Singapore 3.418
CN - Cina 1.681
SE - Svezia 1.168
BR - Brasile 1.152
IT - Italia 980
FR - Francia 638
VN - Vietnam 547
UA - Ucraina 530
GB - Regno Unito 356
IE - Irlanda 347
IN - India 281
FI - Finlandia 234
ID - Indonesia 223
JP - Giappone 201
BD - Bangladesh 197
RU - Federazione Russa 179
TR - Turchia 168
HK - Hong Kong 134
CA - Canada 133
PL - Polonia 117
AR - Argentina 116
MX - Messico 86
IQ - Iraq 66
NL - Olanda 63
ES - Italia 56
KR - Corea 54
AT - Austria 49
ZA - Sudafrica 45
BE - Belgio 40
SA - Arabia Saudita 33
EC - Ecuador 32
IR - Iran 30
PK - Pakistan 30
CO - Colombia 29
AU - Australia 25
CZ - Repubblica Ceca 25
VE - Venezuela 25
MA - Marocco 23
CI - Costa d'Avorio 21
EG - Egitto 21
UZ - Uzbekistan 21
CH - Svizzera 20
LT - Lituania 20
TN - Tunisia 20
JM - Giamaica 19
JO - Giordania 19
PH - Filippine 18
IL - Israele 16
KE - Kenya 16
PT - Portogallo 16
EU - Europa 15
NP - Nepal 14
RO - Romania 14
AZ - Azerbaigian 13
HU - Ungheria 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
PE - Perù 12
UY - Uruguay 12
ET - Etiopia 11
CR - Costa Rica 10
DZ - Algeria 10
KZ - Kazakistan 10
OM - Oman 9
PY - Paraguay 9
AL - Albania 8
BG - Bulgaria 8
HN - Honduras 8
NI - Nicaragua 7
BH - Bahrain 6
GR - Grecia 6
LV - Lettonia 6
RS - Serbia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
MY - Malesia 5
TW - Taiwan 5
AO - Angola 4
BY - Bielorussia 4
BZ - Belize 4
KG - Kirghizistan 4
KH - Cambogia 4
LB - Libano 4
MM - Myanmar 4
MO - Macao, regione amministrativa speciale della Cina 4
PA - Panama 4
SN - Senegal 4
TH - Thailandia 4
BN - Brunei Darussalam 3
CG - Congo 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HR - Croazia 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
QA - Qatar 3
Totale 26.836
Salva come PNG Salva come JPEG
Città #
Singapore 1.970
Chandler 1.277
Cologne 1.211
Ashburn 973
San Jose 877
Beijing 384
Dublin 336
Jacksonville 327
New York 282
San Mateo 264
Los Angeles 235
Lauterbourg 205
Jakarta 204
Ho Chi Minh City 183
Tokyo 182
Hefei 181
Milan 181
Nanjing 172
Munich 160
Ann Arbor 150
Wilmington 144
Boston 138
Dearborn 134
Chicago 128
Hanoi 124
Cattolica 123
Rome 123
Nürnberg 119
The Dalles 118
Hong Kong 116
Frankfurt am Main 108
Princeton 107
São Paulo 105
Izmir 103
Houston 85
Marseille 85
Moscow 78
Dallas 72
Helsinki 71
Seattle 68
Santa Clara 65
Bremen 62
Essen 61
Nanchang 60
Buffalo 59
Woodbridge 59
Lawrence 57
Warsaw 57
Boardman 56
Redwood City 53
Council Bluffs 52
Lancaster 47
Seoul 47
Hangzhou 45
Fairfield 44
Pune 44
Kent 43
Brooklyn 39
Norwalk 38
Turku 37
Brussels 36
Rio de Janeiro 36
Tukwila 36
Kraków 35
Mountain View 35
Paris 35
St Louis 35
Toronto 35
Hebei 34
Shanghai 34
Belo Horizonte 33
Hyderabad 33
Nuremberg 33
Tianjin 33
Amsterdam 32
Atlanta 31
Da Nang 31
Guangzhou 31
Shenyang 31
Baghdad 30
Denver 29
London 29
Mexico City 29
Montreal 29
Stockholm 29
Augusta 28
Chennai 28
Johannesburg 27
Jiaxing 26
Lappeenranta 26
University Park 26
Changsha 25
Detroit 25
Orem 25
Düsseldorf 24
Kunming 24
San Francisco 24
Leawood 23
Haiphong 22
Abidjan 21
Totale 14.116
Salva come PNG Salva come JPEG
Nome #
3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management 1.356
A) Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. 369
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 329
A) Infliximab in the treatment of steroid-dependent ulcerative colitis. 317
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 267
13C-methionine breath tests for mitochondrial liver function assessment. 265
Growth hormone in inflammatory bowel disease 263
13C-breath tests in the study of microsomal liver function 247
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 235
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms 229
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 224
134C-breath tests in the study of mitochondrial liver function 218
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 212
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 211
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 210
13C-breath tests in the study of microsomial liver function 204
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 200
13C-methionine breath tests for mitochondrial liver function assessment 194
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 192
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 190
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 189
A) Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure 178
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 174
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab 174
Ileal Crohn's disease: CEUS determination of activity 173
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 173
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 172
[Helicobacter pylori and gastric carcinoma] 172
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 171
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 171
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations. 170
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 169
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 169
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 168
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity 167
13C-breath tests in the study of mitochondrial liver function 166
A) Study of liver function in healthy elderly subjects using the 13C-methacetin breath test 164
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 164
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 162
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 162
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 159
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 159
Helicobacter pylori treatment: a role for probiotics? 156
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? 156
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 156
Levofloxacin based regimens for the eradication of Helicobacter pylori 155
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 154
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease - A comprehensive narrative review 153
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 151
A) Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice? 148
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 148
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 146
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication 144
Probiotics and Helicobacter pylori eradication 144
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity 144
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 143
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 142
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease. 141
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 141
Infliximab in Crohn's disease: early and long-term treatment. 140
A novel pathogenic role for microvasculature in inflammatory bowel disease. 140
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery 140
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 139
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 134
Biological therapies for inflammatory bowel disease: research drives clinics. 133
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. 133
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 133
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 133
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease 133
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update 132
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 129
Management of perianal fistulas in Crohn's disease: an up-to-date review 129
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 129
Gender affects 13C-ketoisocaproic acid breath test 128
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 126
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 126
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 125
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 125
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 125
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders 124
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 123
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 122
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 122
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 122
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 121
Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach 119
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial 119
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test 118
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease. 117
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 117
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 116
Review article: breath testing for human liver function assessment. 115
Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach 115
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 115
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis 115
Radiomics could predict surgery at 10 years in Crohn's disease 114
Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis 114
Totale 17.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.510 97 120 28 178 43 48 23 246 45 94 269 319
2022/20233.459 421 441 239 540 266 394 163 302 413 98 117 65
2023/20243.061 79 490 61 108 88 270 95 1.196 214 81 179 200
2024/20253.565 67 107 304 82 285 146 181 183 498 378 741 593
2025/20269.617 1.500 305 572 1.065 1.688 449 1.605 470 632 631 385 315
2026/2027254 254 0 0 0 0 0 0 0 0 0 0 0
Totale 27.202